You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sunphenon egcg

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in Berlin, Ulm (Epigallocatechin-Gallate, Placebo)

Completed
  • Alzheimer's Disease
  • Berlin, Germany
  • +2 more
Jul 28, 2021

Multiple Sclerosis Trial in Berlin (Sunphenon EGCG, Placebo)

Completed
  • Multiple Sclerosis
  • Sunphenon EGCG
  • Placebo
  • Berlin, Germany
    Charité Universitätsmedizin Berlin (NeuroCure Clinical Research
Jul 28, 2021

Relapsing-remitting Multiple Sclerosis Trial in Berlin (epigallocatechin-gallate (Sunphenon), )

Completed
  • Relapsing-remitting Multiple Sclerosis
  • epigallocatechin-gallate (Sunphenon)
  • placebo
  • Berlin, Germany
  • +1 more
Jul 28, 2021

Endometriosis Trial in Shatin (SUNPHENON EGCg, Placebo)

Recruiting
  • Endometriosis
  • SUNPHENON EGCg
  • Placebo
  • Shatin, Hong Kong
    Prince of Wales Hospital
Mar 7, 2022

Duchenne Muscular Dystrophy Trial in Berlin, Oldenburg (Epigallocatechin-Gallate, Placebo)

Completed
  • Duchenne Muscular Dystrophy
  • Berlin, Germany
  • +2 more
Jul 28, 2021

Prostate Cancer, Prostate Adenocarcinoma Trial in Tampa (Sunphenon, Placebo)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Tampa, Florida
  • +1 more
Dec 19, 2022

COVID-19 Pneumonia, Tumors Malignant Trial in Jinan (EGCG, Placebo)

Recruiting
  • COVID-19 Pneumonia
  • Neoplasms Malignant
  • Jinan, Shandong, China
    Shandong Cancer Hospital
Mar 5, 2023

Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

Not yet recruiting
  • Cirrhosis, Liver
  • Epigallocatechin gallate (EGCG)
  • Placebo
  • (no location specified)
Aug 27, 2023

Frailty, Inflammation Trial in Rochester (Epigallocatechin-3-Gallate (EGCG), Microcrystalline cellulose (MCC), Ascorbic Acid

Not yet recruiting
  • Frailty
  • Inflammation
  • Epigallocatechin-3-Gallate (EGCG)
  • +2 more
  • Rochester, New York
    University of Rochester
Sep 28, 2023

Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • EGCG + Nintedanib
  • +2 more
  • San Francisco, California
    UCSF Parnassus
Apr 25, 2022

Frailty, Inflammation Trial in Rochester (Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C))

Recruiting
  • Frailty
  • Inflammation
  • Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C)
  • Rochester, New York
    University of Rochester
Aug 15, 2022

No Condition Trial in Chichester (Matcha green tea, Placebo)

Recruiting
  • No Condition
  • Matcha green tea
  • Placebo
  • Chichester, West Sussex, United Kingdom
  • +1 more
May 26, 2023

Irreversible Pulpitis Trial (Epigallocatechin gallate (EGCG), Sodium hypochlorite (NaOCl), Mineral trioxide aggregate (MTA))

Not yet recruiting
  • Irreversible Pulpitis
  • Epigallocatechin gallate (EGCG)
  • +3 more
  • (no location specified)
Apr 12, 2023

Papilloma, Cervix Lesion Trial in Roma (Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid)

Completed
  • Papilloma
  • Cervix Lesion
  • Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid
  • Roma, Italy
    Clinica Alma Res
Dec 21, 2022

Leiomyoma, Uterine Trial (Green Tea Extract, Placebo)

Recruiting
  • Leiomyoma, Uterine
  • Green Tea Extract
  • Placebo
  • New Haven, Connecticut
  • +3 more
Jan 12, 2023

Hypertension, Obesity, Type 2 Diabetes Trial in Baltimore (EGCG)

Withdrawn
  • Hypertension
  • +3 more
  • Baltimore, Maryland
    University of Maryland
Feb 17, 2022

Esophageal Obstruction Trial in Jinan (EGCG)

Recruiting
  • Esophageal Obstruction
  • EGCG
  • Jinan, Shandong, China
    Shan Dong cancer hospital and institute
Sep 3, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Berlin (Capsules with 160 mg Teavigo (at least 94% EGCG), Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Capsules with 160 mg Teavigo (at least 94% EGCG)
  • Placebo
  • Berlin, Germany
    Franz-Volhard Clinical Research Center at the Experimental and C
Jul 28, 2021

Down Syndrome, Fragile X Syndrome Trial in Barcelona (EGCG FontUp, Placebo FontUp)

Completed
  • Down Syndrome
  • Fragile X Syndrome
  • EGCG FontUp
  • Placebo FontUp
  • Barcelona, Spain
    IMIM (Institut Hospital del Mar d'Investigacions Mèdiques)
Jun 10, 2021

Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

Not yet recruiting
  • Breast Cancer Female
  • Triple Negative Breast Cancer
  • quercetin, EGCG, metformin , zinc
  • (no location specified)
Dec 23, 2022

Colon Cancer Trial in San Antonio (Epigallocatechin gallate (EGCG))

Recruiting
  • Colon Cancer
  • Epigallocatechin gallate (EGCG)
  • San Antonio, Texas
    UT Health San Antonio
Dec 13, 2021

Tuberculosis Trial (zinc 50 mg + Epigallocatechin gallate)

Not yet recruiting
  • Tuberculosis
  • zinc 50 mg + Epigallocatechin gallate
  • (no location specified)
Nov 1, 2021

COVID-19, SARS-CoV2 Trial (Previfenon®, Placebo)

Unknown status
  • COVID-19
  • SARS-CoV2
  • (no location specified)
Sep 4, 2020

Impulsivity, Alcohol Consumption Trial in New Haven (Phospholean, Placebo)

Completed
  • Impulsivity
  • Alcohol Consumption
  • Phospholean
  • Placebo
  • New Haven, Connecticut
    John B Pierce Laboratory
Apr 1, 2020

Drug Interaction Trial in Hong Kong (Simvastatin 20 mg (Zocor®, MSD), rosuvastatin 10 mg (Crestor®, Astra Zeneca))

Completed
  • Drug Interaction
  • Simvastatin 20 mg (Zocor®, MSD)
  • rosuvastatin 10 mg (Crestor®, Astra Zeneca)
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
Sep 30, 2021